Full Text
HPR72 EU HTA, Joint Clinical Assessment, and JCA Report: What Is the Possible Impact on Price Negotiation for Orphan Drugs in Germany?

Abstract

Authors

Johanna Tasler Alexandra Meyer Thomas Ecker Janine Leismann

Back to Volume 28, Supplemental Issue 12S1
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×